We evaluate the proposed architecture on two publicly available datasets: the Adverse Drug Events (ADE) dataset BIBREF6 and the CoNLL04 dataset BIBREF7. We show that our architecture is able to outperform the current state-of-the-art (SOTA) results on both the NER and RE tasks in the case of ADE. In the case of CoNLL04, our proposed architecture achieves SOTA performance on the NER task and achieves near SOTA performance on the RE task. On both datasets, our results are SOTA when averaging performance across both tasks. 
 Question: Do they repot results only on English data?
Yes